Neighborhood racial composition and availability of asthma drugs in retail pharmacies

Journal of Asthma

Volumn 42, Issue 9, 2005, Pages 731-735

  Spernak, Stephanie M ^a,d   Mintz, Matthew ^b   Paulson, Jerome ^b,c   Burke, Harry B ^b   Gadkari, Mrinalini ^a   Faselis, Charles ^b   Joseph, Jill G ^c  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

Author keywords

Asthma drugs and equipment; Asthma treatment; Health services; Pharmacies; Racial disparities

Indexed keywords

ANTIASTHMATIC AGENT; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; LEVALBUTEROL; METHYLPREDNISOLONE; MONTELUKAST; PEDIAPRED; PIRBUTEROL ACETATE; PREDNISOLONE; PREDNISONE; SALBUTAMOL; SALBUTAMOL SULFATE; SALMETEROL XINAFOATE; TRIAMCINOLONE ACETONIDE;

ARTICLE; ASTHMA; CAUCASIAN; COLOMBIA; CONTROLLED STUDY; DRUG BIOAVAILABILITY; EQUIPMENT; FREQUENCY ANALYSIS; HEALTH SURVEY; HUMAN; NEGRO; PHARMACIST; RACE DIFFERENCE; RANDOMIZATION; SAMPLE SIZE; TELEPHONE;

AFRICAN CONTINENTAL ANCESTRY GROUP; ANTI-ASTHMATIC AGENTS; CONTINENTAL POPULATION GROUPS; DEMOGRAPHY; DISTRICT OF COLUMBIA; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEALTH CARE SURVEYS; HEALTH SERVICES ACCESSIBILITY; HUMANS; INTERVIEWS; NEBULIZERS AND VAPORIZERS; PHARMACIES; RESIDENCE CHARACTERISTICS;

EID: 28744449991     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900500306480     Document Type: Article

References (13)

1. Oster A, Bindman AB. Emergency department visits for ambulatory care sensitive conditions. Med Care 2003; 41:198-207.
2. Pappas G, Hadden WC, Kozak LJ, Fisher GF. Potentially avoidable hospitalizations: inequalities in rates between US socioeconomic groups. Am J Public Health 1997; 87:811-816.
3. Cunningham J, Dockery DW, Speizer FE. Race, asthma and persistent wheeze in Philadelphia school children. Am J Public Health 1996; 86:1406-1409.
4. Gottlieb DJ, Beiser AS, O'Connor GT. Poverty, race and medication use are correlates of asthma hospitalization rates: a small area analysis in Boston. Chest 1995; 108:28-35.
5. Diaz T, Sturm T, Matte T, Bindra M, Lawler K, Findley S, Maylahn C. Medication use among children with asthma in East Harlem. Pediatrics 2000; 105:1188-1193.
6. Donahue JG, Weiss ST, Livingston JM, Goetsch MA, Greineder DK, Platt R. Inhaled steroids and the risk of hospitalization for asthma. JAMA 1997; 277:887-891.
7. Butz AM, Peyton E, Huss K, Kolodner K, Rand C. Nebulizer use in innercity children with asthma. Arch Pediatr Adolesc Med 2000; 154:984-990.
8. Finkelstein JA, Lozano P, Farber HJ, Miroshnik I, Lieu TA. Underuse of controller medications among Medicaid-insured children with asthma. Arch Pediatr Adolesc Med 2002; 156:562-567.
9. Ford JG, Findley SE, Nachman SA, Trowers RL, McLean DE. Fatal asthma in perspective: relation between individual and community factors. In: Sheffer A, ed. Fatal Asthma. New York, NY: Marcel Dekker Inc., 1998:47.
10. Warman KL, Jacobs AJ, Silver EJ. If we prescribe it, will it come? Access to asthma equipment for Medicaid-insured children and adults in the Bronx, NY. Arch Pediatr Adolesc Med 2002; 156:673-677.
11. Morrison SR, Wallenstein S, Natale DK, Senzel RS, Huang L. "We don't carry that" - failure of pharmacies in predominately nonwhite neighborhoods to stock opioid analgesics. N Engl J Med 2000; 342:1023-1026.
12. Guidelines for the Diagnosis and Management of Asthma, National (U.S.) Asthma Education and Prevention Program. Expert Panel Report II. Bethesda, MD: National Institutes of Health, 2002.
13. Rhodes L, Moorman JE, Redd SC, Mannino DM. Self-reported asthma prevalence and control among adults - United States, 2001. MMWR 2003; 52:381-384.